Who owns Rhythm Pharmaceuticals (RYTM)? Superinvestor holders

4 superinvestors of the 157 tracked here hold Rhythm Pharmaceuticals (RYTM) in their latest 13F filing, with $1.7B between them. Peter Kolchinsky gives it the most weight: 6.43% of the reported portfolio. In their latest reported quarter, Stanley Druckenmiller opened a position; Primecap team reduced.

Hold it now
4
of 157 tracked
Combined value
$1.7B
Bought / sold
1 / 1
last quarter

Key facts

Superinvestors holding it
4 of 157
Biggest holder
Peter Kolchinsky, $740.2M
Largest weight
Peter Kolchinsky, 6.43%of their portfolio
Combined value
$1.7B
Bought last quarter
1
Sold last quarter
1

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding RYTM, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Peter KolchinskyRA Capital Management6.43%$740.2M6.67MNo change0Q2 2026
2Julian and Felix BakerBaker Bros. Advisors3.12%$622.3M5.6MNo change0Q2 2026
3Stanley DruckenmillerDuquesne Family Office0.52%$22.6M203.62KNew+203.62KQ2 2026
4Primecap teamPrimecap Management0.18%$291.8M3.06M▼ Reduced 3.3%−104.57KQ3 2026

Quarter by quarter

Superinvestor ownership of RYTM by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 20269213.06M$291.8M01
Q2 2026157415.64M$1.7B11
Q1 2026157315.69M$1.4B01
Q4 2025157315.75M$1.7B12
Q3 2025157416.57M$1.7B11
Q2 2025157417.06M$1.1B12
Q1 2025156418.29M$969M03
Q4 2024156419.91M$1.1B02

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of RYTM held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Primecap team3.06M3.17M3.42M3.48M4.26M4.88M5.79M6.57M
Peter Kolchinsky·6.67M6.67M6.67M5.68M5.56M6.08M6.08M
Julian and Felix Baker·5.6M5.6M5.6M5.6M5.6M5.6M6.08M
Stanley Druckenmiller·203.62K——————
Takis Sparaggis————1.02M1.02M817.7K1.17M

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own RYTM?

In their latest 13F filings: Peter Kolchinsky (6.43% of the portfolio, $740.2M), Julian and Felix Baker (3.12% of the portfolio, $622.3M), Stanley Druckenmiller (0.52% of the portfolio, $22.6M), Primecap team (0.18% of the portfolio, $291.8M).

Who bought RYTM last quarter?

Stanley Druckenmiller (new position). “Last quarter” is each investor's latest reported quarter.

Who sold RYTM last quarter?

Reduced: Primecap team (3.3% fewer shares).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns Rhythm Pharmaceuticals (RYTM)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/RYTM/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to RYTM by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.